- Business Model
- B2B
- Website
- qritive.com
- Total Funding
- $7.5M
- Last Round
- $7.5M Series AJan 2023
- Rounds
- 1
About
Qritive harnesses AI and innovative technologies to empower pathologists in delivering better disease care. The company offers a growing portfolio of AI-powered diagnostic modules supporting pathologists in identifying and grading cancers, aiming to improve accuracy and speed of cancer diagnosis.
Summary
Qritive is an Artificial Intelligence company. It has raised $7.5M in total across 1 round, most recently a $7.5M Series A round in Jan 2023. Investors include MassMutual Ventures, Enterprise Singapore Seeds Capital and Exfinity Venture Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2023
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...